1469910-70-0Dapagliflozin 5- Member Ring Impurity
● In Stock
| Catalogue No.: | VE006378 |
|---|---|
| CAS No.: | 1469910-70-0 |
| Mol. Formula: | C25H25ClO6 |
| Mol. Weight: | 408.87 g/mol |
Additional information on CAS 1469910-70-0
Parent drug
DapagliflozinIUPAC Name
(1S)-1, 4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitolPharmacopoeial Synonyms
N/AOther Synonyms
Dapagliflozin Furanose Isomer; (2S,3R,4R,5S)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-[(1S)-1,2-dihydroxyethyl]oxolane-3,4-diol; (2S,3R,4R,5S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-5-((S)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diolSmile
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H](O3)[C@H](CO)O)O)O)ClInChI
InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)20-18(25)19(26)21(28-20)17(24)11-23/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18+,19+,20-,21-/m0/s1Description
Dapagliflozin 5-Member Ring Impurity, also known Dapagliflozin Furanose Isomer; (2S,3R,4R,5S)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-[(1S)-1,2-dihydroxyethyl]oxolane-3,4-diol is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Dapagliflozin. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications. Also known as Dapagliflozin furanose isomer, it was evaluated for use during the study of the Development of New Domino Reactions of Alkylidene Meldrum’s Acids Involving Friedel-Crafts Chemistry and Catalytic Conjugate Allylation of Alkylidene Meldrum’s Acids.
References
‘Dumas, Aaron. Development of New Domino Reactions of Alkylidene Meldrum’s Acids Involving Friedel-Crafts Chemistry and Catalytic Conjugate Allylation of Alkylidene Meldrum’s Acids. uwspace.uwaterloo.ca/bitstream/handle/10012/4784/Dumas_Aaron.pdf?sequence=1&isAllowed=y. Accessed 18 Oct. 2021. ?’Request a Quote
"*" indicates required fields









